Annual Total Debt
$77.38 M
-$4.88 M-5.93%
31 December 2023
Summary:
AbCellera Biologics annual total debt is currently $77.38 million, with the most recent change of -$4.88 million (-5.93%) on 31 December 2023. During the last 3 years, it has risen by +$72.99 million (+1662.64%). ABCL annual total debt is now -5.93% below its all-time high of $82.26 million, reached on 31 December 2022.ABCL Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$71.40 M
-$655.00 K-0.91%
30 September 2024
Summary:
AbCellera Biologics quarterly total debt is currently $71.40 million, with the most recent change of -$655.00 thousand (-0.91%) on 30 September 2024. Over the past year, it has dropped by -$9.36 million (-11.59%). ABCL quarterly total debt is now -15.03% below its all-time high of $84.03 million, reached on 30 June 2023.ABCL Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABCL Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.9% | -11.6% |
| 3 y3 years | +1662.6% | +137.5% |
| 5 y5 years | +2147.7% | - |
ABCL Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.9% | +1662.6% | -15.0% | +137.5% |
| 5 y | 5 years | -5.9% | +2147.7% | -15.0% | |
| alltime | all time | -5.9% | +2147.7% | -15.0% |
AbCellera Biologics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $71.40 M(-0.9%) |
| June 2024 | - | $72.05 M(-2.1%) |
| Mar 2024 | - | $73.61 M(-4.9%) |
| Dec 2023 | $77.38 M(-5.9%) | $77.38 M(-4.2%) |
| Sept 2023 | - | $80.76 M(-3.9%) |
| June 2023 | - | $84.03 M(+1.1%) |
| Mar 2023 | - | $83.13 M(+1.1%) |
| Dec 2022 | $82.26 M | $82.26 M(+8.1%) |
| Sept 2022 | - | $76.11 M(+106.9%) |
| June 2022 | - | $36.78 M(-8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $40.28 M(+0.5%) |
| Dec 2021 | $40.06 M(+812.6%) | $40.06 M(+33.3%) |
| Sept 2021 | - | $30.06 M(-9.6%) |
| June 2021 | - | $33.24 M(+79.6%) |
| Mar 2021 | - | $18.51 M(+321.5%) |
| Dec 2020 | $4.39 M(-36.3%) | $4.39 M(-17.6%) |
| Sept 2020 | - | $5.33 M(>+9900.0%) |
| June 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $6.89 M(+100.2%) | $6.89 M |
| Dec 2018 | $3.44 M | - |
FAQ
- What is AbCellera Biologics annual total debt?
- What is the all time high annual total debt for AbCellera Biologics?
- What is AbCellera Biologics annual total debt year-on-year change?
- What is AbCellera Biologics quarterly total debt?
- What is the all time high quarterly total debt for AbCellera Biologics?
- What is AbCellera Biologics quarterly total debt year-on-year change?
What is AbCellera Biologics annual total debt?
The current annual total debt of ABCL is $77.38 M
What is the all time high annual total debt for AbCellera Biologics?
AbCellera Biologics all-time high annual total debt is $82.26 M
What is AbCellera Biologics annual total debt year-on-year change?
Over the past year, ABCL annual total debt has changed by -$4.88 M (-5.93%)
What is AbCellera Biologics quarterly total debt?
The current quarterly total debt of ABCL is $71.40 M
What is the all time high quarterly total debt for AbCellera Biologics?
AbCellera Biologics all-time high quarterly total debt is $84.03 M
What is AbCellera Biologics quarterly total debt year-on-year change?
Over the past year, ABCL quarterly total debt has changed by -$9.36 M (-11.59%)